Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome
Methodological detailsAGREEII-compliant processes, GRADE framework, consumer engagement
- AGREEII-compliant processes
- GRADE framework
- Consumer engagement
Recommendations
As issued by the authors
Further refinement of individual diagnostic criteria, a simplified diagnostic algorithm, and AMH levels as an alternative to US in adults only
Strengthened recognition of broader features of polycystic ovary syndrome (PCOS): metabolic risk factors, CVD, sleep apnoea, very high prevalence of psychological features, and high risk for adverse pregnancy outcomes
Emphasis on the poorly recognized, diverse burden of disease and the need for greater healthcare professional education, evidence-based patient information, improved models of care, and shared decision-making, alongside greater research
Maintained emphasis on healthy lifestyle, emotional well-being, and quality of life, with awareness and consideration of weight stigma
Emphasis on evidence-based medical therapy and cheaper and safer fertility management
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →